Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Brenzavvy discontinuation?When is tenofovir alafenamide patent expiring?Xiaflex market launch year?Are there income restrictions for lipitor's patient program?What's the impact of mixing lipitor bp meds negatively?
See the DrugPatentWatch profile for Omidria
Omidria (phenylephrine and ketorolac injection) received FDA approval on April 10, 2014. [1]
Omidria is used to help improve outcomes in cataract surgery—specifically to reduce the incidence of postoperative ocular pain and constriction (pupillary constriction) during and after cataract procedures. [1]
The FDA’s approval date is listed in the drug’s FDA review/approval history on the FDA label information page for Omidria. [1]
Other Questions About Omidria :